Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Tag: phase

2 posts found

FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.